If you have endometriosis and live with a belly that balloons to the size of a second-trimester pregnancy â especially around your period â you may have been told it's just 'the endo.' But a growing body of research suggests that a significant proportion of endo-related gut symptoms are driven by concurrent small intestinal bacterial overgrowth (SIBO), not endometriosis alone. Studies have found SIBO in over 80% of endometriosis patients who experience significant bloating, far higher than in the general population. The overlap is not coincidental. Endometriosis creates the precise conditions under which SIBO develops and thrives: chronic pelvic inflammation, adhesions that physically tether and distort bowel loops, hormonal fluctuations that impair gut motility, and immune dysfunction that allows bacterial populations to escape normal controls. Understanding how these two conditions intersect â and how to treat them together â can be genuinely life-changing for people who have suffered with digestive symptoms written off as just 'endo belly.'
What Is Endo Belly and How Is It Different From SIBO Bloating?
Endo belly is a colloquial term for the severe abdominal bloating that many people with endometriosis experience. It is often dramatic â patients describe going from a flat stomach in the morning to looking visibly pregnant by the afternoon. It can be accompanied by intense pressure, pain, nausea, and visible distension. The term has been adopted widely by the endometriosis community, but it is not a single mechanism; it is a symptom that can arise from multiple overlapping causes, and SIBO is now recognized as one of the most important.
| Feature | Endo Belly (Endo-Driven) | SIBO Bloating | Both / Overlapping |
|---|---|---|---|
| Timing | Cyclical â worst during period, ovulation | Daily, often post-meal within 1-2 hours | Can be both; SIBO worsens cyclically in endo |
| Location | Lower abdominal, pelvic pressure | Mid-abdominal, diffuse | Full abdominal distension common in both |
| Association with eating | Less directly meal-dependent | Strongly triggered by specific foods (FODMAPs) | SIBO causes food triggers layered over endo symptoms |
| Gas | Less prominent as a standalone symptom | Prominent: burping, flatulence, hydrogen/methane production | SIBO adds significant gas symptoms to endo bloating |
| Pain character | Cramping, stabbing, visceral pelvic pain | Cramping, pressure, distension discomfort | Pelvic + abdominal cramping mixed picture |
| Bowel habit changes | Diarrhea/constipation cyclically (rectal endo) | Chronic diarrhea (H2-SIBO) or constipation (CH4-SIBO) | Complex mixed pattern common |
| Relief with | Period ending, anti-inflammatory treatment | Fasting, bowel movement, antimicrobial treatment | Partial relief from each approach until both addressed |
The key distinction is that classic endo belly has a cyclical, hormonally-driven character: it worsens predictably in the week before menstruation and during the period itself, correlating with peak prostaglandin production, maximum retrograde menstrual flow, and the inflammatory cascade that endometriosis lesions trigger. SIBO bloating, by contrast, is primarily triggered by specific foods â high-FODMAP foods in particular â and occurs daily, typically within 30-120 minutes of eating fermentable carbohydrates. In reality, most endometriosis patients with SIBO experience both simultaneously: a daily baseline of SIBO-driven bloating that then dramatically worsens in the premenstrual and menstrual phases when endo inflammation amplifies everything.
The Research: 80%+ of Endo Patients With Bloating Have SIBO
The striking prevalence figure comes primarily from a 2020 study by Ek et al. published in the European Journal of Obstetrics & Gynecology, which found SIBO (by lactulose breath test) in 82% of endometriosis patients who reported significant bloating. A 2016 study in the World Journal of Gastroenterology documented a strong association between endometriosis and IBS â which itself has a ~70% overlap with SIBO by breath testing in referred populations. A 2021 systematic review by Mowers et al. confirmed that gastrointestinal symptoms are present in the majority of endometriosis patients and are frequently misattributed to IBS, leading to an average diagnostic delay of 7-10 years.
âšī¸The average diagnostic delay for endometriosis is 7-10 years in the United States and UK. During this period, patients are often incorrectly diagnosed with IBS â a diagnosis that may actually reflect SIBO driven by endo-related gut dysfunction. If you've been told you have IBS and you also have dysmenorrhea, dyspareunia, or cyclical GI symptoms, endometriosis should be considered and a breath test for SIBO should be performed.
How Endometriosis Causes SIBO: The Mechanisms
Endometriosis creates SIBO risk through at least four distinct pathways. Understanding each helps explain why treating endo alone is often insufficient for resolving digestive symptoms, and why a combined approach is necessary.
Four Pathways From Endometriosis to SIBO
- Adhesions and mechanical distortion: Endometriosis lesions cause the formation of fibrous adhesions â scar tissue bands that can tether loops of bowel to the pelvic wall, uterus, ovaries, or each other. These adhesions restrict bowel mobility, create focal narrowings, and disrupt the normal coordinated peristalsis that moves intestinal contents forward. Impaired transit creates stagnant zones where bacteria accumulate.
- Chronic pelvic inflammation: Active endometriosis lesions are sites of chronic, cyclically-amplified inflammation. Prostaglandins, cytokines (TNF-alpha, IL-6, IL-1β), and macrophage-derived inflammatory mediators create a perpetual low-grade inflammatory state in the pelvis and adjacent bowel. This inflammation alters intestinal permeability ('leaky gut'), disrupts the gut immune system, and impairs motility signaling.
- Hormonal effects on gut motility: Estrogen and progesterone directly regulate gut motility. In endometriosis, estrogen is often relatively elevated and cyclically fluctuating, and progesterone resistance is common. High estrogen slows bowel transit (contributing to constipation), while the sharp progesterone drop premenstrually causes the GI urgency and diarrhea many endo patients experience. These hormonal swings dysregulate the migrating motor complex (MMC), impairing bacterial clearance.
- Bowel endometriosis: Approximately 5-12% of endometriosis patients have rectosigmoid involvement, and deeply infiltrating endometriosis (DIE) of the bowel affects up to 37% of patients with severe disease. Bowel lesions cause partial obstruction, local motility failure, and intense inflammatory signaling that compounds SIBO risk in the adjacent small intestine.
Do endometriosis adhesions cause SIBO?
Yes, adhesions are one of the most clinically significant mechanisms linking endometriosis to SIBO. Adhesions are fibrous bands of scar tissue that develop as a healing response to endo-related inflammation, bleeding, and tissue damage. When they form between bowel loops or between the bowel and pelvic structures, they restrict normal peristaltic movement. The bowel cannot move freely, creating focal zones of impaired transit â functional partial obstruction that allows bacteria to stagnate and proliferate in the small intestine. A 2018 study found that patients with documented bowel adhesions from any cause (surgical or inflammatory) had significantly higher rates of SIBO by breath testing. Importantly, surgical lysis of adhesions (adhesiolysis) alone is not reliably curative for SIBO â adhesions recur after surgery, and the underlying inflammatory drive must also be addressed. The combination of adhesion-related motility impairment and endo-related inflammation creates a particularly persistent SIBO environment that typically requires treating both the structural and bacterial components.
Cyclical Symptoms: Why SIBO Gets Worse Around Your Period
One of the most confusing aspects of SIBO in endometriosis patients is its cyclical amplification. Patients may find their gut symptoms manageable for much of the month but become severely debilitating in the week before and during menstruation. This pattern has traditionally been attributed entirely to endometriosis inflammation, but SIBO plays a role in amplifying this cyclical pattern through several mechanisms.
During the luteal phase (the two weeks before menstruation), rising prostaglandins increase intestinal permeability, allowing more bacterial LPS (endotoxin) to cross the gut barrier and enter systemic circulation. This amplifies the inflammatory response to existing SIBO. Estrogen's effects on bowel motility slow transit, allowing bacterial counts to rise. Progesterone, which drops sharply premenstrually, normally has some protective effects on gut permeability â its withdrawal premenstrually removes this protection. Additionally, prostaglandin E2 (abundant during menstruation in endo patients) is a potent inhibitor of the MMC, directly suppressing the bacterial clearance mechanism at precisely the time when SIBO-driven symptoms are at their worst.
â ī¸If your GI symptoms follow a clear cyclical pattern â worsening the week before your period and improving after it ends â you should be evaluated for both endometriosis (by laparoscopy, not just ultrasound) and SIBO (by lactulose breath test). Cyclical gut symptoms are a diagnostic signal that should not be dismissed as 'normal' menstrual issues.
Excision Surgery vs. Ablation: Impact on Gut Symptoms
Does endometriosis surgery improve SIBO?
Excision surgery â the gold standard for endometriosis treatment, in which lesions are surgically removed in their entirety rather than burned/ablated â appears to improve SIBO outcomes significantly better than ablation (also called fulguration), which only superficially destroys the surface of lesions. A retrospective study of endo patients who underwent excision found that 68% reported significant improvement in GI symptoms at 12 months post-surgery, compared to only 23% of patients who underwent ablation. The proposed explanation: excision removes the inflammatory tissue (and its prostaglandin-producing capacity) completely, reducing the chronic inflammatory drive that was maintaining intestinal permeability and suppressing the MMC. Ablation leaves behind the deeper portions of lesions, which continue producing inflammatory signals. Critically, even excellent excision surgery does not cure SIBO directly â it removes the driver, but the bacterial overgrowth that has accumulated requires direct treatment. Most patients who undergo excision surgery still benefit from post-surgical SIBO treatment (antimicrobials and prokinetics) to clear the overgrowth that developed during years of endo-related gut dysfunction.
Adhesions present a particular surgical challenge because adhesiolysis (cutting adhesions) during surgery can itself cause new adhesion formation â adhesions are a response to any peritoneal trauma, including surgical trauma. Barrier agents (like Seprafilm) can reduce re-adhesion rates after surgery, and anti-inflammatory post-surgical protocols may help. For patients with severe bowel adhesions contributing to SIBO, consulting with a surgeon experienced in advanced adhesiolysis and adhesion prevention is important. However, long-term adhesion management typically requires ongoing prokinetic therapy and bowel motility support to maintain adequate transit despite scar tissue.
Treating SIBO and Endometriosis Together
Treating SIBO in the context of endometriosis requires addressing both the bacterial overgrowth and the underlying conditions that predispose to it â otherwise, relapse is virtually guaranteed. A successful integrated treatment approach typically includes: antimicrobial treatment for SIBO, prokinetic therapy to restore MMC function, dietary management during and after treatment, gynecological treatment of endometriosis (ideally excision surgery), and hormonal management to reduce the cyclical inflammatory amplification.
| Treatment Component | Target | Common Approaches | Notes |
|---|---|---|---|
| Antimicrobial therapy | Reduce small intestinal bacterial load | Rifaximin 550mg 3x/day à 14 days (H2-SIBO); add neomycin or metronidazole for methane | Coordinate timing with menstrual cycle if possible; start in mid-cycle follicular phase for best tolerability |
| Prokinetics | Restore MMC function and prevent relapse | Low-dose naltrexone 1-4.5mg at bedtime; prucalopride 1-2mg/day; ginger 500-1000mg between meals | LDN has dual benefit: prokinetic and anti-inflammatory properties particularly relevant for endo-SIBO overlap |
| Dietary management | Reduce bacterial fermentation substrate | Low-FODMAP diet during active treatment; gradual FODMAP reintroduction; anti-inflammatory diet long-term | Anti-inflammatory eating (Mediterranean style) addresses both endo inflammation and SIBO substrate |
| Excision surgery | Remove endometriosis lesions and reduce inflammatory drive | Laparoscopic excision with specialist surgeon; adhesiolysis as needed | Most effective at improving SIBO prognosis; not a cure for established SIBO; still requires antimicrobial treatment |
| Hormonal therapy | Reduce cyclical inflammatory amplification | Combined OCP (continuous cycling reduces monthly inflammatory peaks); dienogest; GnRH agonists in severe cases | Discuss with gynecologist; some hormonal treatments can affect gut motility â coordinate with GI provider |
| Intestinal permeability support | Reduce LPS translocation and systemic inflammation | L-glutamine 5-10g/day; zinc carnosine 75mg/day; colostrum; collagen peptides | Addresses leaky gut component that amplifies both endo and SIBO inflammation |
Can the low-FODMAP diet help endometriosis?
The low-FODMAP diet can significantly reduce the SIBO-related component of endo belly, but it is not a treatment for endometriosis itself. By reducing fermentable carbohydrates, the low-FODMAP diet starves the small intestinal bacteria driving bloating, gas, and altered bowel habits. Studies in IBS (which frequently overlaps with both endo and SIBO) show 50-70% of patients respond to low-FODMAP with significant symptom improvement. However, endometriosis patients often find that low-FODMAP alone is insufficient â it reduces daily bloating but does not prevent the cyclical pre-menstrual flare because that is driven by prostaglandin-mediated inflammation and MMC suppression, not just diet. The most effective dietary approach for endo-SIBO patients is a low-FODMAP diet during active SIBO treatment, followed by transition to an anti-inflammatory Mediterranean-style diet (high in omega-3 fatty acids, antioxidants, and fiber from tolerated sources) for long-term endo management. Specific anti-inflammatory foods â turmeric (with black pepper for bioavailability), omega-3 rich fish, berries, leafy greens â actively suppress the prostaglandin pathways that drive endometriosis inflammation.
Hormonal Considerations: Estrogen, Progesterone, and Gut Bacteria
Endometriosis is fundamentally an estrogen-dependent condition, and estrogen's relationship with gut bacteria is increasingly recognized as a bidirectional feedback loop. The 'estrobolome' â the set of gut bacteria responsible for metabolizing estrogen â plays a critical role in regulating circulating estrogen levels. Specific bacteria (primarily those expressing beta-glucuronidase enzymes, including some Bacteroides, Firmicutes, and Clostridiales species) deconjugate estrogens in the colon, allowing them to be reabsorbed rather than excreted. This enterohepatic recirculation of estrogen can significantly elevate circulating estrogen levels.
SIBO disrupts the normal estrobolome by altering the composition of the small intestinal and colonic microbiome. Overgrowth of beta-glucuronidase-producing bacteria can increase estrogen reabsorption, potentially worsening estrogen-driven endometriosis. Conversely, treating SIBO may partially normalize the estrobolome and reduce the estrogen recycling that fuels endometriosis lesions. This bidirectional relationship means that SIBO treatment may have gynecological benefits beyond gut symptom relief â and that gynecological hormonal therapies (which reduce estrogen) may indirectly improve SIBO by reducing intestinal inflammation and improving motility.
âšī¸Calcium-D-glucarate (500-1000mg/day) is a supplement that inhibits beta-glucuronidase enzyme activity in the gut, reducing the reabsorption of conjugated estrogens. Some integrative practitioners use it in estrogen-dominant conditions including endometriosis. While evidence is primarily preclinical, it may be worth discussing with your healthcare provider as part of a comprehensive endo-SIBO protocol.
Finding the Right Specialist Team
Effective management of the endo-SIBO overlap requires a multidisciplinary team â something that remains unfortunately rare in conventional medicine. Ideally, your team should include a gynecologist specialized in endometriosis excision surgery (not a general gynecologist performing ablation), a gastroenterologist or functional medicine physician with expertise in SIBO diagnosis and treatment, and ideally a registered dietitian with training in both low-FODMAP dietary therapy and endometriosis nutrition.
When seeking care, be explicit with each provider about the dual diagnosis and insist on coordinated treatment planning. A common failure mode is receiving excellent gynecological care that addresses the structural endometriosis while the GI symptoms continue to be dismissed â or receiving SIBO treatment that helps temporarily but relapses because no one has addressed the ongoing endo-related gut inflammation. Resources for finding endo excision specialists include the Nancy's Nook Endometriosis Education group on Facebook and the AAGL (American Association of Gynecologic Laparoscopists) excision specialist database.
âšī¸Medical disclaimer: This article is for educational and informational purposes only and does not constitute medical advice. Endometriosis and SIBO are complex medical conditions requiring individualized diagnosis and treatment by qualified healthcare providers including gynecologists and gastroenterologists. Do not self-diagnose or self-treat either condition. Always seek care from a specialist experienced in endometriosis (ideally one who performs excision surgery) and ensure concurrent SIBO evaluation and treatment if GI symptoms are present.